Screener
Praxis Precision Medicines, Inc. PRAX Total Revenue
Discontinued — last reported Q4 '25
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Praxis Precision Medicines, Inc.’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 8:02 AM EST
- Fiscal year
- FY2025
- Accession
- 0001689548-26-000029
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Collaboration revenue | — | $8,553 | $2,447 |
| Operating expenses: | |||
| Research and development | 267,115 | 152,413 | 86,766 |
| General and administrative | 59,083 | 56,305 | 42,054 |
| Total operating expenses | 326,198 | 208,718 | 128,820 |
| Loss from operations | (326,198) | (200,165) | (126,373) |
| Other income: | |||
| Other income, net | 22,930 | 17,346 | 3,096 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Praxis Precision Medicines, Inc.'s total revenue?
- Praxis Precision Medicines, Inc. (PRAX) reported total revenue of $0 in Q4 2025.
- How has Praxis Precision Medicines, Inc.'s total revenue changed year-over-year?
- Praxis Precision Medicines, Inc.'s total revenue decreased by 100.0% year-over-year, from $7.46M to $0.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Praxis Precision Medicines, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude